Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel for Thrombus Burden in PAD
NCT02407314Phase 4Terminated
- Sponsor
- Arkansas Heart Hospital
- Start
- Jun 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in Peripheral Arterial Disease (PAD), sponsored by Arkansas Heart Hospital. Started Jun 2015; status: terminated.
02
Drugs
ticagrelor
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02407314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407314.